Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00577590 · ClinicalTrials.gov registry record · NA
Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DM
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 78
- Enrollment target
NCT00577590 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 78 participants.
The verdict
NCT00577590, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
Study Summary
Type 2 Diabetes Mellitus (T2DM) is a disease that interferes with the body's proper production and use of insulin, a hormone needed to convert sugar into usable energy. People with Type 2 Diabetes Mellitus (T2DM) are at a higher risk for certain cardiovascular diseases, including heart disease and stroke. Normal treatments for Type 2 Diabetes Mellitus (T2DM) target blood sugar levels only, but there is reason to believe that also targeting blood fat levels will improve both sugar metabolism and heart function in people with Type 2 Diabetes Mellitus, (T2DM.) This study will determine the effectiveness of blood-fat lowering treatments along with blood-sugar control treatments in improving heart function and symptoms of people with Type 2 Diabetes Mellitus(T2DM), and if this varies between men and women.
Interventions
- DRUG Metformin
- DRUG Rosiglitazone
- DRUG Lovaza
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2003-10 |
| Est. Completion | 2012-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00577590
The ClinicalTrials.gov registry entry for NCT00577590 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Metformin is the first listed.
NCT00577590 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00577590 about?
NCT00577590 is a clinical study titled "Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DM". Type 2 Diabetes Mellitus (T2DM) is a disease that interferes with the body's proper production and use of insulin, a hormone needed to convert sugar into usable energy. People with Type 2 Diabetes Mellitus (T2DM) are at a higher risk for certain cardiovascular diseases, including heart disease and s...
What is the current status of trial NCT00577590?
This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2003-10. Estimated completion is 2012-09.
What interventions are being tested in trial NCT00577590?
The interventions under investigation include: Metformin (DRUG), Rosiglitazone (DRUG), Lovaza (DRUG).
Who is sponsoring clinical trial NCT00577590?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.